For this reason, the company Towa Pharmaceutical, will carry out the voluntary collection of batch n.º T002, valid in November 2024, of the drug Rasagilina toLife, 1 mg, tablet, with registration numbers 5664750 and 5664768, said Infarmed in a statement published on the website.

As a result of this situation, the National Authority for Medicines and Health Products determined “the immediate suspension” of the marketing of this batch.

Infarmed warns entities that have this batch of medicine in 'stock' not to sell, dispense or administer it, and must return it.